Pioneering medical device company with patented technologies in the "key hole" surgery market
days to go:
Expired
investment:
£600,083
Span Health is a digital care platform that aims to help people avoid lifestyle-induced diseases, symptoms, medication, and complications. The company has helped more than 10,000 people to live a better and longer life. Span Health's easy-to-use mobile application allows patients to chat with clinicians, order blood tests at home, book video consultations, and see results in the application itself. Moreover, in 2019, the company agreed on a National Health Service (NHS) pilot test for 100 patients in collaboration with the National Institute of Health Research in North West London. Span Health will use the investment to provide employees with blood tests to screen for health risk factors and recover from detected illness safely and sustainably, improve its platform data insights, prediction and machine learning to better structure the clinician's processes, and further reduce its operational costs.
days to go:
Expired
investment:
£134,892
The largest built database comprised of residential and commercial properties in the UK, collated from over 500 reputable sources. Nimbus has information for more than 25m leasehold and freehold properties, in addition to 900k unregistered sites, which can all be easily viewed on a digital map. The company expects their current user base of 5.5k to increase to 240k by 2021 and their monthly sales to grow at a similar rate from £92k in April 2018.
days to go:
Expired
investment:
£366,030
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
days to go:
Expired
investment:
£2,005,050
International Ambulances (IA) aims to save lives and to provide better outcomes for patients, paramedics and hospitals. The company is building a revolutionary ambulance the 'ACESO' that will be the first ever purpose built global ambulance. ACESO will address known challenges of accident & emergency departments and promote the NHS 'See and Treat' strategy. Of the ambulance fleet size of 14,000, International Ambulances (IA) has identified about 1,200 A&E Ambulances of which the opportunity for ACESO is 500 per year.
days to go:
Expired
investment:
£251,600
Accunea is the world’s first real-time continuous organ function monitoring company, specializing in biomarkers for kidney transplantation. Targeting NHS hospitals in the UK undertaking renal transplantation, the company aims to provide relief to patients awaiting organ transplants by ensuring availability of more organs for transplant and reducing the numbers of deaths due to increasing waiting list times. For this purpose, the company has designed a miniature analysis device which constantly monitors markers of kidney function and metabolism through a standard dribble line put into the vein of a patient. Accunea is raising £400,000 at a pre-money valuation of £2,230,000. The funds will be used to achieve clinical utility in Kidney and Pancreas.
days to go:
Expired
investment:
£388,038
CrowdProperty is a specialist property project lending platform that matches quality property professionals undertaking quality property projects with institutional/private investors of capital for value-creating property projects. It seeks to ensure profits for borrowers, lenders, the under-supplied UK housing environment, and the UK economy through its business model. The company claims to have recently closed a £300 million funding line from a global asset manager. It has lent upwards of £140 million with £180 million+ originated facilities, gained recognition by Deloitte Fast50 and FT1000 as a 'High Growth Business', and built a proprietary and scalable technology platform. CrowdProperty has also launched CrowdProperty Australia, leveraging its asset-class expertise, scalable proprietary technology and IP from the UK business in the Australian market. The company states it will use the investment to grow its property team, evolve its technology platform further, acquire more customers, and grow its business.
days to go:
Expired
investment:
£1,815,319
The LetPal solution for private landlords is a full suite of competitively priced on-line services, from which landlords can select and pay for only those they require.
days to go:
Expired
investment:
£70,000
Infabode is a platform that aims to update users with news on the real estate industry information around the globe. It has over 40,000 users and 900 content partners on its portal. The company aims to benefit users by being the most accurate portal for real estate data in the world, and content providers by increasing the reach of their insights and brand. In 2020, Infabode partnered with real estate portal, Cherre, for continued expansion into the US. The company also raised £250,000 from existing and new investors, matched by the Government's future fund, in July 2020. Infabode was shortlisted for EG's Real Estate Digital Outstanding Achievement Award. The company will use the investment to get the business to breakeven by Q2 2021. It will also explore a larger Series A funding and/or a corporate sale, both of which were being considered, pre-COVID-19.
days to go:
Expired
investment:
£291,000
Howsy is an online marketplace for renting. Howsy does away with traditional over-priced and under-serviced lettings model, bringing down the cost of managing a property by an estimated 75%. Their team of 81, operate across three locations—two in the UK and one in South East Asia. The company has also been featured in publications such as Forbes and The Guardian as well as portals such as TechCityNews and Startups.co.uk. The company will use the investment to build a digital service that makes renting easier, qualify for the 'Future Fund', a government support package for start-ups, and towards building working capital and growth marketing.
days to go:
Expired
investment:
£2,346,770
